Inogen, Inc. (INGN)
6.155
+0.02
(+0.41%)
USD |
NASDAQ |
Mar 19, 16:00
6.155
0.00 (0.00%)
After-Hours: 20:00
Inogen Shareholders Equity (Quarterly) : 192.23M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp. | 24.23B |
| Globus Medical, Inc. | 4.573B |
| Corcept Therapeutics, Inc. | 647.80M |
| Cytokinetics, Inc. | -659.62M |
| Apellis Pharmaceuticals, Inc. | 370.15M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 298.62M |
| Total Liabilities (Quarterly) | 106.39M |
| Debt to Equity Ratio | 0.0909 |
| Current Ratio | 3.121 |
| Net Debt Paydown Yield | 0.29% |